Cancer Immunology and Immunotherapy (CII) | CSR

Dr. Syed Quadri, Branch Chief

CII Review Branch Personnel

Review Branch Summary

Will consider applications on preclinical and early clinical studies of treatments for cancer. Specifically, the CII branch reviews applications on understanding the immunology associated with cancer and the development and understanding of immunotherapies for cancer treatment.

Study Sections